Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 USD | -3.77% | -3.43% | -78.13% |
05-22 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
05-15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-78.13% | 820K | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- VRPX Stock
- News Virpax Pharmaceuticals, Inc.
- Virpax Pharmaceuticals, Inc. Appoints Michèle C. Linde as the Executive Vice President, General Counsel and Corporate Secretary